A dog dewormer that fights cancer — or a viral story science can't yet confirm?
Fenbendazole was developed to clear intestinal worms from livestock. It was never meant for oncology. Yet it belongs to a drug family that targets tubulin — the same protein exploited by some of medicine's most established chemotherapy agents — and laboratory evidence of its effects on cancer cells is real, replicated, and taken seriously by researchers.
What science reveals is more complicated than either believers or skeptics tend to allow. The clinical evidence gap is not a conspiracy; it is a structural consequence of patent economics. The preclinical signal is genuine but bounded. And the distance between mechanism and therapy has swallowed far more promising compounds than this one.
Inside, you'll discover:
– Why fenbendazole's mechanism is scientifically credible — and why credibility is not the same as proof
– What the laboratory studies actually showed, and where their findings stop
– Why the question remains genuinely open, and what answering it would require
What Science Says About... is a series for readers who want evidence, not certainty — explore the full collection.
Read it before drawing conclusions.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. Print on Demand. N° de réf. du vendeur I-9798187049547
Quantité disponible : Plus de 20 disponibles